🚀 VACDIVA Final World Technology Transfer Workshop: Shaping the Future of ASF Control On December 12th, 2024, the VACDIVA Final World Technology Transfer Workshop gathered key stakeholders at the European Economic and Social Committee (Brussels) to present and discuss the project’s key results and next steps in the fight against African Swine Fever (ASF). 🔹 Highlights from the workshop: ✅ Two promising ASF vaccine candidates wereshowcased, offering significant protection. ✅ Development of DIVA diagnostic tools, essential for differentiating infected and vaccinated animals. ✅ Insights from international organizations, including DG Agri, DG Santé, DG Research, FAO, and World Organisation for Animal Health . ✅ Discussions on field implementation, regulatory challenges, and the urgent need to secure further funding to build on these achievements. The workshop emphasized the importance of collaboration between science, policymakers, and the livestock sector to ensure ASF solutions can become a reality. 🔗 Read the full article here: https://lnkd.in/d2JdPHKR #VACDIVA #ASF #AfricanSwineFever #H2020 #Innovation #LivestockSector European Research Executive Agency (REA)
About us
African Swine Fever (ASF) is one of the most important viral diseases affecting swine, with a serious socio-economic impact. It is present in more than 13 countries in Europe (10 in the EU), 28 sub-Saharan African countries, and 2 Asian countries, China and Mongolia. No vaccine is available and recent incursions in Europe and Asia are jeopardizing the pig industry worldwide. Control of ASF is based on early diagnosis and the implementation of strict sanitary measures. However, measures taken by affected countries have not been sufficient to stop spread. The objective of VACDIVA is to solve the ASF problem in Europe and affected countries through innovation efforts. VACDIVA will provide (1) Three safe and effective pilot vaccines for wild boar and domestic pigs ready for registration; (2) validated companion DIVA tests and 3) cost-benefit and effective surveillance and control-vaccination strategies, with field trials in Lithuania and Kenia. Two world leader companies in vaccine production and ASF diagnostic kits will provide production of the new vaccines and DIVA tests. Epidemiological modelling of worldwide scenarios will be offered in a portfolio of services to help animal health authorities control and eradicate the disease. This project will provide policy makers valuable decision support tools to better prevent and control ASF. VACDIVA counts with the expertise of two world ASF Reference Laboratories (OIE and FAO), the EU reference laboratory (EURL), six EU national Reference Laboratories (of 6 out of the 10 countries currently affected by ASF) and four prestigious ASF research institutions. Participation of Russian, Chinese and African laboratories will provide useful support, increasing acceptance of the vaccines. Active involvement of pig producers, agricultural associations and International agencies like FAO will enlarge the impact of communication, dissemination and training activities.
- Website
-
http://vacdiva.eu/
External link for VACDIVA
- Industry
- Research Services
- Company size
- 201-500 employees
- Headquarters
- European Union, European Union
- Type
- Public Company
- Founded
- 2019
Locations
-
Primary
Get directions
European Union, European Union 28040, OO
Updates
-
📢 VACDIVA Final World Technology Transfer Workshop 🚀 The VACDIVA project is organizing its Final World Technology Transfer Workshop on December 12th, 2024, in Brussels at the European Economic and Social Committee (EESC). This workshop marks a major milestone in the fight against African Swine Fever (ASF), showcasing key results and advances in vaccine development achieved over the course of the project. 🔹 Discussions will engage leading scientists, policymakers, and industry stakeholders to highlight impactful outcomes and future strategies. 🔗 More details: https://lnkd.in/d7wyDJFg #VACDIVA #ASF #AfricanSwineFever #Innovation #Research #DGResearch #H2020 #EESCPartnership #EESC
-
On April 20th, at the 70th General Assembly of the International Council for Game and Wildlife Conservation (CIC) , Professor José Manuel Sánchez-Vizcaíno shared the promising results of our project, VACDIVA, aimed at combating African Swine Fever. We're proud to contribute to this vital initiative by developing field application models for the vaccine in Spain and other affected regions. #AfricanSwineFever #VACDIVA #WildlifeConservation European Research Executive Agency (REA)
El pasado día 20 de abril, dentro del programa desarrollado en la 70a Asamblea General del International Council for Game and Wildlife Conservation (CIC), el profesor José Manuel Sánchez-Vizcaíno presentó los resultados del proyecto destinado a lograr una vacuna frente a la Peste Porcina Africana (VACDIVA). Antes de la charla, el vicepresidente del CIC, D. Arpad Sarkany puso en valor el valor del proyecto y la gran importancia del mismo, así como el apoyo del CIC. En INGULADOS estamos muy orgullosos de participar en dicho proyecto y que VACDIVA haya contado con nosotros para el desarrollo de los modelos de aplicación en campo de la vacuna tanto en España como en otros países en donde en la actualidad existen brotes de la enfermedad.
-